Comparative prospective study of two liver graft preservation solutions: University of Wisconsin and Celsior

Liver Transplantation

Volumn 15, Issue 12, 2009, Pages 1709-1717

  Lopez Andujar, Rafael ^a   Deusa, Saulo ^a   Montalvá, Eva ^a   San Juan, Fernando ^a   Moya, Angel ^a   Pareja, Eugenia ^a   DeJuan, Manuel ^a   Berenguer, Marina ^a   Prieto, Martín ^a   Mir, Jose ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CELSIOR; CYCLOSPORIN; STEROID; TACROLIMUS; UNIVERSITY OF WISCONSIN SOLUTION;

ACUTE KIDNEY FAILURE; ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIARY TRACT DISEASE; BILIRUBIN BLOOD LEVEL; BONE METASTASIS; CEREBROVASCULAR ACCIDENT; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYTOLYSIS; DECOMPENSATED LIVER CIRRHOSIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; GRAFT SURVIVAL; HEART ARREST; HEMATOTHORAX; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER GRAFT; LIVER PRESERVATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; REPERFUSION INJURY; RESPIRATORY FAILURE; SEPSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; VASCULAR DISEASE;

ADENOSINE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLOPURINOL; BILIARY TRACT DISEASES; DISACCHARIDES; ELECTROLYTES; FEMALE; GLUTAMATES; GLUTATHIONE; GRAFT SURVIVAL; HISTIDINE; HUMANS; INSULIN; LIVER; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MANNITOL; MIDDLE AGED; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PILOT PROJECTS; POSTOPERATIVE HEMORRHAGE; PRIMARY GRAFT DYSFUNCTION; PROSPECTIVE STUDIES; RAFFINOSE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES; YOUNG ADULT;

EID: 71249164164     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21945     Document Type: Article

References (32)

1. NIH consensus development conference statement. Liver transplantation. Hepatology 1984;4:1075-1095.
2. Belzer FO. Clinical organ preservation with UW solution. Transplantation 1989;47:1097.
3. Haller GW, Langrehr JM, Blumhardt G, Platz KP, Müller A, Bechstein WO, et al. Factors relevant to the development of primary dysfunction in liver allografts. Transplant Proc 1995;27:1192.
4. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T. Risk factors for primary dysfunction after liver transplantation. A multivariate analysis. Transplantation 1993;55:807-813.
5. Markmann JF, Markmann JW, Desai NM, Baquerizo A, Singer J, Yersiz H, et al. Operative parameters that predict the outcomes of hepatic transplantation. J Am Coll Surg 2003;196:566-572. (Pubitemid 36428261)
6. Markmann JF, Markmann JW, Markmann DA, Bacquerizo A, Singer J, Holt CD, et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation 2001;72:1113-1122. (Pubitemid 32924087)
7. Adam R, Bismuth H, Diamond T, Ducot B, Morino M, Astarcioglu I, et al. Effect of extended cold ischemia with UW solution on graft function after liver transplantation. Lancet 1992;340:1373-1376.
8. Cofer JB, Klintmalm GB, Howard TK, Morris CV, Husberg BS, Goldstein RM, Gonwa TA. A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation 1990;49:1088-1093. (Pubitemid 20227632)
9. Menasche P, Termignon JL, Pradier F, Grousset C, Mouas C, Alberici G, et al. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg 1994;8:207-213.
10. Baldan N, Toffano M, Cadrobbi R, Codello L, Calabrese F, Bacelle L, et al. Kidney preservation in pigs using Celsior, a new organ preservation solution. Transplant Proc 1997;29:3539-3540. (Pubitemid 28008587)
11. Audet M, Alexandre E, Mustun D, David P, Chenard-Neu MP, Tiollier J, et al. Comparative evaluation of Celsior versus Viaspan in a pig liver transplantation model. Transplantation 2001;71:1731-1735. (Pubitemid 32622482)
12. Straatsburg IH, Abrahamse SL, Song SW, Hartman RJ, Van Gulik TM. Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and Celsior. Transplantation 2002;74:458-464. (Pubitemid 34977672)
13. Faenza A, Catena F, Nardo B, Montalti R, Capocasale E, Busi N, et al. Kidney preservation with University of Wisconsin and Celsior solution: a prospective multicenter randomized study. Transplantation 2001;72:1274-1277. (Pubitemid 33026608)
14. Boggi U, Vistoli F, Del Chiaro M, Signori S, Croce C, Pietrabissa A, et al. Pancreas preservation with University of Wisconsin and Celsior solutions: a single-center, prospective, randomized pilot study. Transplantation 2004;77:1186-1190. (Pubitemid 38580294)
15. Maggi U, Caccamo L, Gatti S, Paone G, Reggiani P, Rossi G, et al. Celsior solution and clinical liver transplantation. Transplant Proc 2000;32:36-37. (Pubitemid 30100745)
16. Meneu Diaz JC, Vicente E, Nuño J, Quijano Y, Lopez-Hervás P, Bárcena R, et al. Prospective comparative study of the efficacy of Celsior solution for preservation in clinical liver transplant. Transplant Proc 2002;34:49. (Pubitemid 34311564)
17. Lama C, Rafecas A, Figueras J, Torras J, Ramos E, Fabregat J, et al. Comparative study of Celsior and Belzer solutions for hepatic graft preservation: preliminary results. Transplant Proc 2002;34:54.
18. Cavallari A, Cillo U, Nardo B, Filipponi F, Gringeri E, Montalti R, et al. A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation. Liver Transpl 2003;9:814-821. (Pubitemid 36974947)
19. Pedotti P, Cardillo M, Rigotti P, Gerunda G, Merenda R, Cillo U, et al. A comparative prospective study of two available solutions for kidney and liver preservation. Transplantation 2004;77:1540-1545. (Pubitemid 38703034)
20. Garcia-Gil FA, Arenas J, Guemes A, Esteban E, Tomé-Zelaya E, Lamata F, et al. Preservation of the liver graft with Celsior solution. Transplant Proc 2006;38:2385-2388. (Pubitemid 44693690)
21. Starzl TE, Miller C, Broznick B, Makowka L. An improved technique for multiple organ harvesting. Surg Gynecol Obstet 1987;65:343-348. (Pubitemid 17161530)
22. Bruna M, López-Andújar R, Montalvá E, Redondo C, Moya A, San Juan F, et al. Donors yesterday and today: have the characteristics of liver donors changed over the last 15 years [in Spanish]? Cir Esp 2008;83:194-196.
23. De Oliveira ML, McCormack L, Clavien PA. Clinical and experimental aspects of preservation injury in liver grafts. Curr Opin Organ Transplant 2006;11:213-218. (Pubitemid 43804770)
24. Canelo R, Hakim NS, Ringe B. Experience with histidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation. Int Surg 2003;9:145-151. (Pubitemid 39625496)
25. Moench C, Moench K, Lohse AW, Thies J, Otto G. Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion. Liver Transpl 2003;9:285-289. (Pubitemid 36322331)
26. Nardo B, Beltempo P, Bertelli R, Montalti R, Vivarelli M, Urbani L, et al. Comparison of Celsior and University of Wisconsin solutions in cold preservation of liver from octogenarian donors. Transplant Proc 2004;36:523-524. (Pubitemid 38534309)
27. Chan SC, Liu CL, Lo CM, Fan ST. Applicability of histidine-tryptophan- ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation. Liver Transpl 2004;10:1415-1421. (Pubitemid 39530058)
28. Erhard J, Lange R, Scherer R, Kox WJ, Bretschneider HJ, Gebhard MM, Eigler FW. Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. A prospective, randomized study. Transpl Int 1994;7:177-181. (Pubitemid 24111677)
29. Aguilera V, Berenguer M, Rubín A, San Juan F, Rayón JM, Prieto M, Mir J. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): posttransplantation outcome. Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis. Liver Transpl 2009;15:79-87.
30. Berenguer M, Prieto M, San Juan F, Rayón JM, Martínez F, Carrasco D, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002;36:202-210. (Pubitemid 34700779)
31. Samuel D, Forns X, Berenguer M, Trautwein C, Burroughs A, Rizzetto M, Trepo C. Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). J Hepatol 2006;45:127-143. (Pubitemid 43850627)
32. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001;35:666-678.